Free Market Accountability Project Big Pharma's 'Orange' Threat Level

With patent reform about to return to the legislative docket, lobbyists and advocacy groups are scrambling either to try to cram in their various pet ideas, or to kill the project altogether. I hate to say it, but the reform-killers are almost preferable, since their strategy doesn’t usually require messing with the content of the bills. Those trying to alter what is being debated, on the other hand, are almost never doing so with anything but naked crony capitalism in mind. And they have hired the best crony capitalists around, including even one of the architects of Obamacare.

Read More